Left Ventricular Assist Device (LVAD) as a Bridge to Recovery for Tachycardia-Mediated Cardiomyopathy

Michael B Stokes; Pankaj Saxena; Justin A Mariani; David M Kaye; Peter Bergin; David C McGiffin

doi:10.1111/jocs.12632

Left Ventricular Assist Device (LVAD) as a Bridge to Recovery for Tachycardia-Mediated Cardiomyopathy

J Card Surg. 2015 Nov;30(11):871-3. doi: 10.1111/jocs.12632. Epub 2015 Sep 8.

Authors

Michael B Stokes¹, Pankaj Saxena², Justin A Mariani¹, David M Kaye¹, Peter Bergin¹, David C McGiffin²

Affiliations

¹ Department of Advanced Heart Failure and Transplantation, The Alfred Hospital and Monash University, Melbourne, Australia.
² Department of Cardiothoracic Surgery, The Alfred Hospital and Monash University, Melbourne, Australia.

PMID: 26350745
DOI: 10.1111/jocs.12632

Abstract

A case is described of cardiogenic shock that occurred following use of sotalol in a patient with severe left ventricular dysfunction. The patient required left ventricular assist device (LVAD) placement with subsequent myocardial recovery to a degree that allowed eventual device removal following 140 days of support.

Publication types

Case Reports

MeSH terms

Anti-Arrhythmia Agents / adverse effects
Cardiomyopathies / etiology
Cardiomyopathies / therapy*
Heart Ventricles*
Heart-Assist Devices*
Humans
Male
Middle Aged
Severity of Illness Index
Shock, Cardiogenic / etiology
Shock, Cardiogenic / therapy*
Sotalol / adverse effects
Tachycardia / etiology
Tachycardia / therapy*
Time Factors
Treatment Outcome
Ventricular Dysfunction, Left / complications

Substances

Anti-Arrhythmia Agents
Sotalol